Infusystem Holdings Inc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Infusystem Holdings Inc's ROA in the third quarter of 2026?
Infusystem Holdings Inc achieved a return on average assets (ROA) of 9.41 % in its third quarter of 2026, this is above INFU's average return on assets of 1.05%.
Infusystem Holdings Inc assets over the 12 months ending in its third quarter of 2026 are valued at $100 million

Despite the company's net income deteriorating, Infusystem Holdings Inc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 106 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 779, from total ROA ranking in the second quarter of 2026 at 1101.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	5.7 %	-3.12 %	-5.39 %	-2.95 %	-6.1 %
Y / Y Net Income Change	39.71 %	24.32 %	-	118.22 %	25.01 %
Net Income (TTM) in million	9	9	8	7	6
Return On Assets (TTM)	9.41 %	8.63 %	7.93 %	6.55 %	5.42 %
INFU's Total Ranking	# 779	# 1101	# 1126	# 1205	# 1582
Total Assets (TTM) in million	105	98	99	101	99
Seq. Total Assets Change	6.98 %	-0.97 %	-1.89 %	1.7 %	-1.95 %
Seq. Net Income Change	-2.32 %	217.7 %	-50.05 %	-9.87 %	-13.08 %

INFU's 5 Years Annual ROA >> Back to INFU Management Effectiveness >> Compare INFU ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 32
Sector	# 107
Overall	# 712

Return On Assets Statistics
High	Average	Low
20.93 %	1.05 %	-28.79 %
(Mar 31 2021)		(Sep 30 2018)

Financial Statements
Infusystem Holdings Inc's Assets	$ 105 million	INFU's Balance sheet
Infusystem Holdings Inc's Income	$ 3 million	Quarterly INFU's Income Statement
INFU's Income by Division		See INFU's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-2.95 %	0.68 %	3.55 %	1.85 %	0.61 %
Total Assets in million	101	104	103	99	98
Y / Y Net Income Change	182.6 %	168.92 %	4744.44 %	-98.73 %	-91.81 %
Net Income in million	7	2	1	0	1
Annual Return On Assets	6.59 %	2.26 %	0.85 %	0.02 %	1.46 %

INFU's 5 Years Annual ROA >> Back to INFU Management Effectiveness >> Compare INFU ROA to its Competitors

Comment on INFU's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 6.59 % compared to prior year, due to annual net income growth of 182.6 % to $6.63 million, and due to decline of value in Infusystem Holdings Inc's assets by -2.95 % to $100.56 million, compared to $100.56 a year before.

More Return On Assets Ratios
INFU's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INFU's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for INFU's Competitors
Subscribers only: Roa for Infusystem Holdings Inc's Suppliers
Subscribers only: Return On Assets for INFU's Customers

You may also want to know
INFU's Roi	INFU's Inventory Turnover Ratio	INFU's Growth Rates	INFU's Dividend Comparisons
	INFU's Profitability Ratios	INFU's Asset Turnover Ratio	INFU's Dividend Growth
INFU's Roe	INFU's Valuation Ratios	INFU's Financial Strength Ratios	INFU's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Caredx Inc	25.74 %
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %

Date modified: 2026-11-10T10:00:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.